Prostate Cancer Mortality at 11 years of Follow-up in the ERSPC

BACKGROUND: Several trials have evaluated the effect of prostate-specific antigen (PSA)-based screening on prostate cancer (PC) mortality, with conflicting results. We report on the mortality in the European Randomized Trial of Screening for Prostate Cancer (ERSPC) with two added years of follow-up....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Principais autores: Schröder, FH, Hugosson, J, Roobol, MJ, Tammela, TLJ, Ciatto, S, Nelen, V, Kwiatkowski, M, Lujan, M, Lilja, H, Zappa, M, Denis, LJ, Recker, F, Páez, A, Määttänen, L, Bangma, CH, Aus, G, Carlsson, S, Villers, A, Rebillard, X, Van der Kwast, Th, Kujala, PM, Blijenberg, BG, Stenman, UH, Huber, A, Taari, K, Hakama, M, Moss, SM, de Koning, HJ, Auvinen, A
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6027585/
https://ncbi.nlm.nih.gov/pubmed/22417251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1113135
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados